Parenteral excipients are substances used in the formulation of injectable drugs. They are an important component of parenteral products as they help to stabilize, solubilize, and enhance the delivery of active pharmaceutical ingredients (APIs) to the patient.
Pharma Excipients
Parenteral Excipients
Long-acting transdermal drug delivery formulations: Current developments and innovative…
Transdermal administration remains an active research and development area as an alternative route for long-acting drug delivery. It avoids major drawbacks of conventional oral (gastrointestinal side effects, low drug bioavailability, and need for multiple dosing) or parenteral routes (invasiveness,…
Read More...
Read More...
Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for…
Abstract
Parenteral administration is one of the most commonly used drug delivery routes for nanoparticle-based dosage forms, such as lipid-based and polymeric nanoparticles. For the treatment of various diseases, parenteral administration include intravenous, subcutaneous, and intramuscular…
Read More...
Read More...
Closer to the Formulator (C2F) – A Center of Excellence by DFE Pharma
DFE Pharma is a global leader in pharma and nutraceutical excipient solutions. They develop, produce and supply high quality functional excipients for use in the pharmaceutical, biopharmaceutical, and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral…
Read More...
Read More...
BIOHALE® – Products for the Stabilization of Biologics
BioHale® is DFE Pharma´s, high-purity, low-endotoxin product portfolio for the stabilization of biologics. Because stability matters.
BioHale® Key promises:
Uncompromised quality
Security of supply
Expert support
Uncompromised quality
BioHale® high purity and low endotoxin…
Read More...
Read More...
Resomer® and Lactel® Portfolio of Excipients for Parenteral Controlled Release by Evonik
A broad, versatile range of standard, custom and specialized parenteral excipients
The RESOMER® and LACTEL® portfolios provide an industry-leading selection of functional excipients for parenteral controlled release. As an expert provider of custom and specialized parenteral excipients, we offer…
Read More...
Read More...
BASF Pharma Solutions introducing a new shear protectant – Kolliphor® P188 Cell Culture
On March 11th, 2024, BASF Pharma Solutions officially announced the launch of Kolliphor® P188 Cell Culture – This new shear protectant is a GMP material for bioprocessing applications where a lower average molecular weight poloxamer could be beneficial.
Kolliphor® P188 Cell Culture joins…
Read More...
Read More...
Troubleshooting and FAQs for KLEPTOSE® β-cyclodextrins and hydroxypropyl-β-cyclodextrins
See some Frequently Asked Questions and the corresponding answers for Cyclodextrins and KLEPTOSE®:
What are ß-Cyclodextrins (ß-CDs)?
β-Cyclodextrins (β-CDs) are cyclic oligosaccharides with a bucket-like structure having a hydrophobic internal cavity and a hydrophilic exterior. This unique…
Read More...
Read More...
From Seed to Solution: The Unrivaled Quality of ADM Refined Sesame Oil IV-1 in Pharma
ADM Refined Sesame Oil IV-1 is a highly purified sesame oil, fully compliant with the:
"European Pharmacopoeia (0433) and United States Pharmacopeia/National Formulary (USP/NF) monographs and general notices"
intended for use in the manufacturing of pharmaceutical products.…
Read More...
Read More...
Precision in Every Drop: The Potential of Refined Soybean Oil in Lipophilic Drugs
ADM´s Refined Soybean Oil IV is a highly purified soybean oil fully compliant with the:
"European Pharmacopoeia (1473) and United States Pharmacopeia/National Formulary (USP/ NF) monographs and general notices"
intended for use in the manufacturing of pharmaceutical products.…
Read More...
Read More...
Effects of excipients on the interactions of self-emulsifying drug delivery systems with human blood…
Due to its versatility in formulation and manufacturing, self-emulsifying drug delivery systems (SEDDS) can be used to design parenteral formulations. Therefore, it is necessary to understand the effects of excipients on the behavior of SEDDS formulations upon parenteral administration, particularly…
Read More...
Read More...